BackgroundComputer-aided detection (CAD) software analyzes chest X-rays for features suggestive of tuberculosis (TB) and provides a numeric abnormality score. However, estimates of CAD accuracy for TB screening are hindered by the lack of confirmatory data among people with lower CAD scores, including those without symptoms. Additionally, the appropriate CAD score thresholds for obtaining further testing may vary according to population and client characteristics. MethodsWe screened for TB in Ugandan individuals aged [&ge;]15 years using portable chest X-rays with CAD (qXR v3). Participants were offered screening regardless of their symptoms. Those with X-ray scores above a threshold of 0.1 (range, 0 - 1) were asked to provide sputum for Xpert Ultra testing. We estimated the diagnostic accuracy of CAD for detecting Xpert-positive TB when using the same threshold for all individuals (under different assumptions about TB prevalence among people with X-ray scores <0.1), and compared this estimate to age- and/or sex-stratified approaches. FindingsOf 52,835 participants screened for TB using CAD, 8,949 (16.9%) had X-ray scores [&ge;]0.1. Of 7,219 participants with valid Xpert Ultra results, 382 (5.3%) were Xpert-positive, including 81 with trace results. Assuming 0.1% of participants with X-ray scores <0.1 would have been Xpert-positive if tested, qXR had an estimated AUC of 0.920 (95% confidence interval 0.898-0.941) for Xpert-positive TB. Stratifying CAD thresholds according to age and sex improved accuracy; for example, at 96.1% specificity, estimated sensitivity was 75.0% for a universal threshold (of [&ge;]0.65) versus 76.9% for thresholds stratified by age and sex (p=0.046). InterpretationThe accuracy of CAD for TB screening among all screening participants, including those without symptoms or abnormal chest X-rays, is higher than previously estimated. Stratifying CAD thresholds based on client characteristics such as age and sex could further improve accuracy, enabling a more effective and personalized approach to TB screening. FundingNational Institutes of Health Research in contextO_ST_ABSEvidence before this studyC_ST_ABSThe World Health Organization (WHO) has endorsed computer-aided detection (CAD) as a screening tool for tuberculosis (TB), but the appropriate CAD score that triggers further diagnostic evaluation for tuberculosis varies by population. The WHO recommends determining the appropriate CAD threshold for specific settings and population and considering unique thresholds for specific populations, including older age groups, among whom CAD may perform poorly. We performed a PubMed literature search for articles published until September 9, 2024, using the search terms "tuberculosis" AND ("computer-aided detection" OR "computer aided detection" OR "CAD" OR "computer-aided reading" OR "computer aided reading" OR "artificial intelligence"), which resulted in 704 articles. Among them, we identified studies that evaluated the performance of CAD for tuberculosis screening and additionally reviewed relevant references. Most prior studies reported area under the curves (AUC) ranging from 0.76 to 0.88 but limited their evaluations to individuals with symptoms or abnormal chest X-rays. Some prior studies identified subgroups (including older individuals and people with prior TB) among whom CAD had lower-than-average AUCs, and authors discussed how the prevalence of such characteristics could affect the optimal value of a population-wide CAD threshold; however, none estimated the accuracy that could be gained with adjusting CAD thresholds between individuals based on personal characteristics. Added value of this studyIn this study, all consenting individuals in a high-prevalence setting were offered chest X-ray screening, regardless of symptoms, if they were [&ge;]15 years old, not pregnant, and not on TB treatment. A very low CAD score cutoff (qXR v3 score of 0.1 on a 0-1 scale) was used to select individuals for confirmatory sputum molecular testing, enabling the detection of radiographically mild forms of TB and facilitating comparisons of diagnostic accuracy at different CAD thresholds. With this more expansive, symptom-neutral evaluation of CAD, we estimated an AUC of 0.920, and we found that the qXR v3 threshold needed to decrease to under 0.1 to meet the WHO target product profile goal of [&ge;]90% sensitivity and [&ge;]70% specificity. Compared to using the same thresholds for all participants, adjusting CAD thresholds by age and sex strata resulted in a 1 to 2% increase in sensitivity without affecting specificity. Implications of all the available evidenceTo obtain high sensitivity with CAD screening in high-prevalence settings, low score thresholds may be needed. However, countries with a high burden of TB often do not have sufficient resources to test all individuals above a low threshold. In such settings, adjusting CAD thresholds based on individual characteristics associated with TB prevalence (e.g., male sex) and those associated with false-positive X-ray results (e.g., old age) can potentially improve the efficiency of TB screening programs.

BackgroundArtificial Intelligence (AI) is rapidly changing the legal landscape of radiology. Results from a previous experiment suggested that providing AI error rates can reduce perceived radiologist culpability, as judged by mock jury members (4). The current study advances this work by examining whether the radiologists behavior also impacts perceptions of liability. Methods. Participants (n=282) read about a hypothetical malpractice case where a 50-year-old who visited the Emergency Department with acute neurological symptoms received a brain CT scan to determine if bleeding was present. An AI system was used by the radiologist who interpreted imaging. The AI system correctly flagged the case as abnormal. Nonetheless, the radiologist concluded no evidence of bleeding, and the blood-thinner t-PA was administered. Participants were randomly assigned to either a 1.) single-read condition, where the radiologist interpreted the CT once after seeing AI feedback, or 2.) a double-read condition, where the radiologist interpreted the CT twice, first without AI and then with AI feedback. Participants were then told the patient suffered irreversible brain damage due to the missed brain bleed, resulting in the patient (plaintiff) suing the radiologist (defendant). Participants indicated whether the radiologist met their duty of care to the patient (yes/no). Results. Hypothetical jurors were more likely to side with the plaintiff in the single-read condition (106/142, 74.7%) than in the double-read condition (74/140, 52.9%), p=0.0002. Conclusion. This suggests that the penalty for disagreeing with correct AI can be mitigated when images are interpreted twice, or at least if a radiologist gives an interpretation before AI is used.

Glaucoma is increasingly recognized as a neurodegenerative condition involving both retinal and central nervous system structures. Here, we present an integrated framework that combines MK-Curve-corrected diffusion kurtosis imaging (DKI), tractometry, and deep autoencoder-based normative modeling to detect localized white matter abnormalities associated with glaucoma. Using UK Biobank diffusion MRI data, we show that MK-Curve approach corrects anatomically implausible values and improves the reliability of DKI metrics - particularly mean (MK), radial (RK), and axial kurtosis (AK) - in regions of complex fiber architecture. Tractometry revealed reduced MK in glaucoma patients along the optic radiation, inferior longitudinal fasciculus, and inferior fronto-occipital fasciculus, but not in a non-visual control tract, supporting disease specificity. These abnormalities were spatially localized, with significant changes observed at multiple points along the tracts. MK demonstrated greater sensitivity than MD and exhibited altered distributional features, reflecting microstructural heterogeneity not captured by standard metrics. Node-wise MK values in the right optic radiation showed weak but significant correlations with retinal OCT measures (ganglion cell layer and retinal nerve fiber layer thickness), reinforcing the biological relevance of these findings. Deep autoencoder-based modeling further enabled subject-level anomaly detection that aligned spatially with group-level changes and outperformed traditional approaches. Together, our results highlight the potential of advanced diffusion modeling and deep learning for sensitive, individualized detection of glaucomatous neurodegeneration and support their integration into future multimodal imaging pipelines in neuro-ophthalmology.

While Deep Learning (DL) models trained on Magnetic Resonance Imaging (MRI) have shown promise for prostate cancer detection, their lack of direct biological validation often undermines radiologists trust and hinders clinical adoption. Radiologic-histopathologic (rad-path) correlation has the potential to validate MRI-based lesion detection using digital histopathology. This study uses automated and manually annotated digital histopathology slides as a standard of reference to evaluate the spatial extent of lesion annotations derived from both radiologist interpretations and DL models previously trained on prostate bi-parametric MRI (bp-MRI). 117 histopathology slides were used as reference. Prospective patients with clinically significant prostate cancer performed a bp-MRI examination before undergoing a robotic radical prostatectomy, and each prostate specimen was sliced using a 3D-printed patient-specific mold to ensure a direct comparison between pre-operative imaging and histopathology slides. The histopathology slides and their corresponding T2-weighted MRI images were co-registered. We trained DL models for cancer detection on large retrospective datasets of T2-w MRI only, bp-MRI and histopathology images and did inference in a prospective patient cohort. We evaluated the spatial extent between detected lesions and between detected lesions and the histopathological and radiological ground-truth, using the Dice similarity coefficient (DSC). The DL models trained on digital histopathology tiles and MRI images demonstrated promising capabilities in lesion detection. A low overlap was observed between the lesion detection masks generated by the histopathology and bp-MRI models, with a DSC = 0.10. However, the overlap was equivalent (DSC = 0.08) between radiologist annotations and histopathology ground truth. A rad-path correlation pipeline was established in a prospective patient cohort with prostate cancer undergoing surgery. The correlation between rad-path DL models was low but comparable to the overlap between annotations. While DL models show promise in prostate cancer detection, challenges remain in integrating MRI-based predictions with histopathological findings.

This study explores Artificial Intelligence (AI)s transformative role in diabetes care and monitoring, focusing on innovations that optimize patient outcomes. AI, particularly machine learning and deep learning, significantly enhances early detection of complications like diabetic retinopathy and improves screening efficacy. The methodology employs a bibliometric analysis using Scopus, VOSviewer, and Publish or Perish, analyzing 235 articles from 2023-2025. Results indicate a strong interdisciplinary focus, with Computer Science and Medicine being dominant subject areas (36.9% and 12.9% respectively). Bibliographic coupling reveals robust international collaborations led by the U.S. (1558.52 link strength), UK, and China, with key influential documents by Zhu (2023c) and Annuzzi (2023). This research highlights AIs impact on enhancing monitoring, personalized treatment, and proactive care, while acknowledging challenges in data privacy and ethical deployment. Future work should bridge technological advancements with real-world implementation to create equitable and efficient diabetes care systems.

Background and ObjectivesBottom-of-sulcus dysplasia (BOSD) is a diagnostically challenging subtype of focal cortical dysplasia, 60% being missed on patients first MRI. Automated MRI-based detection methods have been developed for focal cortical dysplasia, but not BOSD specifically. Use of FDG-PET alongside MRI is not established in automated methods. We report the development and performance of an automated BOSD detector using combined MRI+PET data. MethodsThe training set comprised 54 mostly operated patients with BOSD. The test sets comprised 17 subsequently diagnosed patients with BOSD from the same center, and 12 published patients from a different center. 81% patients across training and test sets had reportedly normal first MRIs and most BOSDs were <1.5cm3. In the training set, 12 features from T1-MRI, FLAIR-MRI and FDG-PET were evaluated using a novel "pseudo-control" normalization approach to determine which features best distinguished dysplastic from normal-appearing cortex. Using the Multi-centre Epilepsy Lesion Detection groups machine-learning detection method with the addition of FDG-PET, neural network classifiers were then trained and tested on MRI+PET features, MRI-only and PET-only. The proportion of patients whose BOSD was overlapped by the top output cluster, and the top five output clusters, were assessed. ResultsCortical and subcortical hypometabolism on FDG-PET were superior in discriminating dysplastic from normal-appearing cortex compared to MRI features. When the BOSD detector was trained on MRI+PET features, 87% BOSDs were overlapped by one of the top five clusters (69% top cluster) in the training set, 76% in the prospective test set (71% top cluster) and 75% in the published test set (42% top cluster). Cluster overlap was similar when the detector was trained and tested on PET-only features but lower when trained and tested on MRI-only features. ConclusionDetection of BOSD is possible using established MRI-based automated detection methods, supplemented with FDG-PET features and trained on a BOSD-specific cohort. In clinical practice, an MRI+PET BOSD detector could improve assessment and outcomes in seemingly MRI-negative patients being considered for epilepsy surgery.